Experimental evidence from knock-in mice supports this hypothesis, as female mice carrying the NCF1 AA genotype exhibit splenomegaly, increased IFN scores, the development of autoantibodies, and lupus-like kidney disease following pristane injection. The gene discussed is IFNA1; the disease is kidney disorder.